TSS
INAB icon

Two Sigma Securities’s IN8bio INAB Stock Holding History

Two Sigma Securities’s Portfolio INAB Stock Details INAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,143
Closed -$5.69K – 1779
2025
Q1 		$5.69K Buy
+1,143
New +$9.12K ﹤0.01% 1293
2024
Q3 		– Sell
-2,324
Closed -$59K – 3221
2024
Q2 		$59K Buy
2,324
+1,739
+297% +$55.8K ﹤0.01% 2554
2024
Q1 		$20.7K Buy
+585
New +$22.1K ﹤0.01% 2667
2022
Q3 		– Sell
-995
Closed -$67K – 2834
2022
Q2 		$67K Buy
+995
New +$84.1K ﹤0.01% 1806

Other funds holding INAB

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Securities's INAB Position: Q2 2025 in Review

Two Sigma Securities sold out of IN8bio (INAB) in Q2 2025, closing a stake of 1,143 shares — an estimated $5.69K sold.

Two Sigma Securities first reported a position in INAB in Q2 2022 and held it in 4 quarters. The position peaked at $67K in Q2 2022. 12 funds tracked by Wall St. Rank hold INAB as of Q2 2025.

  • Two Sigma Securities reported no remaining IN8bio position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Securities sold 1,143 IN8bio shares in Q2 2025, an estimated $5.69K.
  • Two Sigma Securities first reported a position in IN8bio in Q2 2022 and held it in 4 quarters.
  • Two Sigma Securities's IN8bio position peaked at $67K in Q2 2022.
  • 12 funds tracked by Wall St. Rank held IN8bio as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.